| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.06 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |